223 related articles for article (PubMed ID: 31734255)
1. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
2. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
Gao KT; Lian D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
[TBL] [Abstract][Full Text] [Related]
4. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
Yang Y; Wang S; Li T
Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.
Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S
Springerplus; 2016; 5(1):1721. PubMed ID: 27777857
[TBL] [Abstract][Full Text] [Related]
6. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
Li F; Cao L; Hang D; Wang F; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
[TBL] [Abstract][Full Text] [Related]
8. [Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on Meta-analysis].
Song W; Wang K; Zhang R; Zou S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1163-1167. PubMed ID: 27932761
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of long non-coding RNA MALAT1 in cancer patients.
Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D
Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614
[TBL] [Abstract][Full Text] [Related]
11. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
13. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
Wei Y; Niu B
Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
Sun Z; Zhang T; Chen B
Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
Meng Y; Liu YL; Li K; Fu T
Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
20. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
